infohep news

• Re-infection with hepatitis C has fallen among people with HIV in Europe

  Keith Alcorn / 20 January 2022

  The rate of re-infection with hepatitis C has fallen sharply among people with HIV in Europe since the introduction of direct-acting antivirals, the EuroSIDA cohort study reports in the journal HIV Medicine. People ...

• Injecting drug use

  One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows

  Keith Alcorn / 11 January 2022

  Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ...

• HIV and HBV

  Hepatitis B may increase cancer risk in people with HIV

  Keith Alcorn / 29 December 2021

  People with both HIV and hepatitis B have a higher rate of non-liver cancers compared to other people with HIV, a large European study has found. The study investigators, who have published ...

• Hepatocellular carcinoma (HCC)

  Some people remain at risk for liver cancer despite hepatitis C treatment

  Liz Highleyman / 22 December 2021

  Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ...

• Antiviral therapy

  Hepatitis B treatment for all who need it an "achievable public health goal" for Malawi

  Keith Alcorn / 13 December 2021

  Providing hepatitis B treatment for everyone who needs it in Malawi is an achievable public health goal, researchers from the Malawi-Liverpool-Wellcome Trust programme report, following community surveys in Blantyre, Malawi. Hepatitis B treatment ...